HK57196A - Cyclosporin compositions for oral administration - Google Patents

Cyclosporin compositions for oral administration

Info

Publication number
HK57196A
HK57196A HK57196A HK57196A HK57196A HK 57196 A HK57196 A HK 57196A HK 57196 A HK57196 A HK 57196A HK 57196 A HK57196 A HK 57196A HK 57196 A HK57196 A HK 57196A
Authority
HK
Hong Kong
Prior art keywords
oral administration
cyclosporin compositions
cyclosporin
compositions
oral
Prior art date
Application number
HK57196A
Other languages
English (en)
Inventor
Armin Meinzer
Birgit Hauer
Ulrich Posanski
Jacky Vonderscher
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK57196(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of HK57196A publication Critical patent/HK57196A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
HK57196A 1991-06-27 1996-04-03 Cyclosporin compositions for oral administration HK57196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
HK57196A true HK57196A (en) 1996-04-12

Family

ID=10697415

Family Applications (2)

Application Number Title Priority Date Filing Date
HK57196A HK57196A (en) 1991-06-27 1996-04-03 Cyclosporin compositions for oral administration
HK157696A HK157696A (en) 1991-06-27 1996-08-22 Transesterified corn oil products

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK157696A HK157696A (en) 1991-06-27 1996-08-22 Transesterified corn oil products

Country Status (38)

Country Link
EP (2) EP0953630B1 (es)
JP (2) JP2653958B2 (es)
KR (3) KR0131064B1 (es)
CN (1) CN1077798C (es)
AT (1) AT403436B (es)
AU (1) AU659460B2 (es)
CA (2) CA2175842C (es)
CH (2) CH685764A5 (es)
CY (1) CY1906A (es)
CZ (1) CZ281790B6 (es)
DE (3) DE4244986B4 (es)
DK (2) DK0539319T3 (es)
EE (1) EE03108B1 (es)
ES (2) ES2142818T3 (es)
FI (2) FI109454B (es)
FR (2) FR2678169B1 (es)
GB (2) GB9113872D0 (es)
GR (1) GR3032366T3 (es)
HK (2) HK57196A (es)
HU (1) HU216792B (es)
IE (1) IE73662B1 (es)
IL (3) IL102310A (es)
IT (1) IT1254401B (es)
LU (1) LU88138A1 (es)
MX (1) MX9203236A (es)
MY (1) MY109512A (es)
NO (2) NO303964B1 (es)
NZ (1) NZ243309A (es)
PH (1) PH30337A (es)
PT (2) PT539319E (es)
RO (2) RO111021B1 (es)
RU (1) RU2143919C1 (es)
SA (1) SA92130213B1 (es)
SK (1) SK278759B6 (es)
TW (1) TW267943B (es)
UA (1) UA35559C2 (es)
UY (1) UY23864A1 (es)
ZA (1) ZA924719B (es)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
DK1033128T4 (da) 1993-09-28 2012-03-19 Scherer Gmbh R P Blød gelatinekapselfremstilling
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
EP0694308A4 (en) * 1994-02-17 1997-09-10 Shiseido Co Ltd CYCLOSPORIN EMULSION COMPOSITION
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ES2133655T3 (es) * 1994-03-31 1999-09-16 Unilever Nv Aceites con bajo contenido de acidos grasos saturados.
IL115742A (en) * 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
EP0869810B1 (en) * 1996-06-19 2004-10-06 Novartis AG Cyclosporin-containing soft capsule preparations
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6306434B1 (en) * 1997-02-12 2001-10-23 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
IL131609A0 (en) * 1997-03-12 2001-01-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
US6258783B1 (en) 1997-04-29 2001-07-10 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
DE69823663T2 (de) * 1997-07-29 2005-05-19 Pharmacia & Upjohn Co., Kalamazoo Selbstemulgierbare formulierung enthaltend lipophile verbindungen
DE69808463T2 (de) 1997-07-29 2003-06-26 Pharmacia & Upjohn Co., Kalamazoo Selbstemulgierende formulierung enthaltend saure lipophile verbindungen
ATE215370T1 (de) * 1997-07-29 2002-04-15 Upjohn Co Selbstemulgierende formulierung enthaltend lipophile verbindungen
US6201165B1 (en) 1997-10-16 2001-03-13 Board Of Regents, University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof
CA2313024C (en) 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
PT982035E (pt) * 1998-08-18 2004-08-31 Panacea Biotec Ltd Composicao de ciclosporina compreendendo um veiculo hidrofilo
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
WO2001032143A1 (en) * 1999-11-02 2001-05-10 Cipla Ltd. A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
BR0113108A (pt) * 2000-08-08 2003-06-10 Kao Corp Composição de óleo/gordura
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
ES2326040T3 (es) 2001-10-19 2009-09-29 Isotechnika Inc. Sintesis de analogos de ciclosporina.
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
WO2008122967A2 (en) 2007-04-04 2008-10-16 Sigmoid Pharma Limited An oral pharmaceutical composition
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
MX2021006010A (es) * 2018-11-26 2021-09-21 Hepion Pharmaceuticals Inc Formulaciones farmaceuticas para analogos de ciclosporina.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (es) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0539319B1 (en) 1999-12-08
FI109454B (fi) 2002-08-15
IL102310A (en) 1997-03-18
HK157696A (en) 1996-08-30
CZ197792A3 (en) 1993-01-13
IE73662B1 (en) 1997-06-18
KR0131064B1 (ko) 1998-04-17
PT539319E (pt) 2000-05-31
KR100231384B1 (en) 1999-11-15
ES2227921T3 (es) 2005-04-01
FR2685706B1 (es) 1994-12-23
JP2653958B2 (ja) 1997-09-17
HU216792B (hu) 1999-08-30
IL102310A0 (en) 1993-01-14
DE4244986B4 (de) 2008-07-24
NO964382L (no) 1992-12-28
DE4244930C2 (de) 1999-11-11
PH30337A (en) 1997-04-02
FI116199B (fi) 2005-10-14
IL118546A0 (en) 1996-10-16
GB2257359A (en) 1993-01-13
NO303964B1 (no) 1998-10-05
FI922958A0 (fi) 1992-06-25
NO325267B1 (no) 2008-03-17
EP0539319A2 (en) 1993-04-28
NO922506D0 (no) 1992-06-25
NZ243309A (en) 1995-02-24
SK197792A3 (en) 1994-03-09
CN1077798C (zh) 2002-01-16
FI961513A (fi) 1996-04-03
CA2175842C (en) 2002-05-07
SK278759B6 (sk) 1998-02-04
CH685764A5 (de) 1995-09-29
CH684163A5 (de) 1994-07-29
DK0539319T3 (da) 2000-05-22
AT403436B (de) 1998-02-25
DE4219526C2 (de) 1999-04-22
AU1852792A (en) 1993-03-11
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
AU659460B2 (en) 1995-05-18
ZA924719B (en) 1993-12-27
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
DE4219526A1 (de) 1993-03-18
FR2685706A1 (fr) 1993-07-02
CY1906A (en) 1992-06-24
CA2072509A1 (en) 1992-12-28
LU88138A1 (fr) 1994-03-01
TW267943B (es) 1996-01-11
JP3420897B2 (ja) 2003-06-30
HUT62201A (en) 1993-04-28
IT1254401B (it) 1995-09-14
KR930000113A (ko) 1993-01-15
FI961513A0 (fi) 1996-04-03
UY23864A1 (es) 1995-05-29
GB9113872D0 (en) 1991-08-14
JPH05186365A (ja) 1993-07-27
CZ281790B6 (cs) 1997-01-15
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
RO111110B1 (ro) 1996-06-28
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
NO964382D0 (no) 1996-10-15
HU9201975D0 (en) 1992-09-28
RO111021B1 (ro) 1996-06-28
FI922958A (fi) 1992-12-28
EP0539319A3 (en) 1993-06-09
IL118546A (en) 1998-09-24
GB9213393D0 (en) 1992-08-05
DK0953630T3 (da) 2004-11-01
ITRM920476A1 (it) 1993-12-23
GB2257359B (en) 1996-01-10
FR2678169A1 (fr) 1992-12-31
EE03108B1 (et) 1998-08-17
RU2143919C1 (ru) 2000-01-10
PT953630E (pt) 2004-11-30
EP0953630B1 (en) 2004-09-08
GR3032366T3 (en) 2000-04-27
FR2678169B1 (fr) 1994-08-26
CA2175842A1 (en) 1992-12-28
KR100231385B1 (en) 1999-11-15
ATA129892A (de) 1997-07-15
ES2142818T3 (es) 2000-05-01
CA2072509C (en) 1996-07-30
CN1079907A (zh) 1993-12-29
EP0953630A1 (en) 1999-11-03

Similar Documents

Publication Publication Date Title
GB2257359B (en) Cyclosporin compositions for oral administration
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
HU9303143D0 (en) Pharmaceutical compositions
GB2270842B (en) Pharmaceutical compositions containing cyclosporins
HU9501950D0 (en) Oral compositions
IL104068A0 (en) Pharmaceutical compositions for inhalation
IL111007A0 (en) Composition containing rapamycin for oral administration
GB9117361D0 (en) Oral dosage form
ZA922834B (en) Pharmaceutical compositions
PL334100A1 (en) Cyclosporin containing compositions for oral administration
PL319898A1 (en) Cyclosporines containing compositions for oral administration
HUT71131A (en) Paramycin formulations for oral administration
GB9100465D0 (en) Pharmaceutical compositions
ZA925171B (en) Pharmaceutical compositions
GB9120672D0 (en) Pharmaceutical compositions
GB9121631D0 (en) Pharmaceutical compositions
GB9102293D0 (en) Oral compositions
IE900393L (en) Pharmaceutical compositions for oral administration
GB9200414D0 (en) Pharmaceutical compositions
GB9418029D0 (en) Pharmaceutical compositions for oral administration
IL93270A0 (en) Pharmaceutical compositions for oral administration
GB9113280D0 (en) Pharmaceutical compositions containing cyclosporine derivatives
GB9113621D0 (en) Pharmaceutical compositions
GB9118128D0 (en) Pharmaceutical compositions
GB9126766D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20120623